Table 1 Clinical characteristics of treatment-naive patients with EHI sample and HCs
From: Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function
Characteristic | Rapid progressors | Chronic progressors | Healthy controls |
|---|---|---|---|
N | 8 | 7 | 11 |
Han ethnic, no. (%) | 8 (100) | 7 (100) | 11 (100) |
Age (years, mean ± SD) | 35.88 ± 10.6 | 28.57 ± 13.99 | 30.5 ± 8.84 |
Male (No. %) | 8 (100) | 7 (100) | 11 (100) |
CD4 (cells/μl, mean ± SD) | 266.5 ± 45.49 | 630.29 ± 116.9 | |
VL (log copies/ml, mean ± SD) | 4.75 ± 0.72 | 3.54 ± 0.78 | |
Sample day (day, mean ± SD) | 99.63 ± 28.04 | 94.71 ± 14.23 |